HLTH

HLTH is a global events and content company that hosts conferences and forums for healthcare innovators, decision-makers, and leaders, with offices in New York, London, and Dublin, and described as UK-based. The organization connects thousands of healthcare professionals, CEOs, and investors to discuss disruptive innovations and health transformation strategies. Its flagship events, such as HLTH US, attract significant scale, with HLTH USA 2024 drawing over 12,000 attendees, building on the inaugural 2018 event which hosted 3,500 attendees, including 700+ CEOs and 300 investors. HLTH was acquired by Hyve Group in October 2024, integrating its over 80 employees into the larger events organization. Jonathan Weiner, Founder and Chairman, continues to lead the company alongside President Rich Scarfo, under the oversight of Hyve Group CEO Mark Shashoua. HLTH was founded by Jonathan Weiner in May 2018.

Based on the search results provided, HLTH is not a company that builds products or offers investment services—it is an annual healthcare innovation conference and community platform organized by HLTH Inc.[4]

High-Level Overview

HLTH is a premier annual conference and community that convenes healthcare industry leaders, innovators, and investors to discuss emerging trends, forge partnerships, and accelerate digital transformation across the healthcare ecosystem.[4][5] The event brings together approximately 12,000 industry leaders and 900 exhibitors representing health systems, pharmaceutical companies, payers, technology firms, and AI startups.[3] Rather than being a traditional company with a product or investment thesis, HLTH functions as a convening platform that shapes the direction of healthcare innovation by highlighting real-world applications, investment trends, and emerging technologies.[6]

The 2025 edition (held October 19-22 in Las Vegas) marked a significant inflection point: healthcare organizations moved beyond exploring AI as a theoretical concept to deploying it operationally across clinical, administrative, and patient engagement functions.[3] This shift reflects HLTH's role as a barometer for where the industry is actually heading, not where it aspires to be.

Core Differentiators

HLTH distinguishes itself through several structural advantages:

• Ecosystem breadth: Unlike conferences focused on a single stakeholder group, HLTH convenes the entire healthcare value chain—health systems, pharma, payers, medtech, and startups—creating rare cross-sector networking opportunities.[4][6]

• Focus on real-world deployment: The conference emphasizes operational implementation and ROI rather than prototype demonstrations, reflecting healthcare's maturation in technology adoption.[3]

• Curated focus areas: HLTH organizes content around specific transformation domains—AI & Emerging Technology, Diagnostics, Employer & Workforce Health, Oral Health, Patient Voice & Impact, and Pharma & Life Sciences—allowing attendees to dive deep into relevant areas.[4]

• Structured innovation showcases: Features like the "AI Innovation Theater," "AI Transformation Zone," and "Market Connect" facilitate both knowledge-sharing and deal-making between startups and established healthcare organizations.[6]

Role in the Broader Healthcare Landscape

HLTH serves as a leading indicator of healthcare technology adoption and investment direction. The conference reflects a fundamental shift in how health systems approach digital transformation: they've evolved from technology adopters to co-creators and architects of solutions, leading 30% of digital health partnerships.[1] This signals that healthcare organizations are no longer passive consumers of vendor solutions but active drivers of innovation that address real operational pain points.

The timing of HLTH's emphasis on AI deployment is critical. Healthcare faces simultaneous pressures—clinician burnout, administrative burden, rising costs, and fragmented data systems—that AI-driven solutions can address at scale.[3][5] By showcasing companies like Aidoc (operational optimization), Buddy Healthcare (care coordination), and PreciseDX (clinical decision support), HLTH validates which technologies are moving from pilot to production.[1]

The conference also influences investment flows by serving as a dealmaking venue where startups gain visibility with health systems and payers, and where established players identify acquisition targets or partnership opportunities.

Quick Take & Future Outlook

HLTH's influence will likely deepen as healthcare organizations demand more sophisticated integration frameworks, governance models, and evidence of clinical and financial ROI from AI investments. The conference's growing emphasis on health equity, interoperability, and workforce optimization suggests that future healthcare innovation will be judged not just on technological sophistication but on whether it actually improves clinician experience and patient outcomes at scale.

As healthcare moves from AI exploration to operationalization, HLTH's role as a trusted convening platform—where health systems, vendors, and investors align on what works—positions it as an essential node in the healthcare innovation ecosystem.